3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Arthritis, Rheumatoid
12
Leukemia
5
Spondylitis, Ankylosing
3
Psoriasis
3
Myelodysplastic Syndromes
3
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Arthritis, Psoriatic
2
Spondylarthritis
1
Respiratory Distress Syndrome
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma
1
Lung Neoplasms
1
Lung Injury
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Inflammatory Bowel Diseases
1
Infections
1
Immunoglobulin Light-chain Amyloidosis
1
Hematologic Neoplasms
1
HIV Infections
1
Gulf War Illness
1
Interventions
Cyclophosphamide
53
Etoposide
33
Temozolomide
28
Irinotecan
28
Melphalan
25
Filgrastim
25
Topotecan
24
Carboplatin
24
3-Iodobenzylguanidine
23
Isotretinoin
20
Granulocyte Colony-Stimulating Factor
17
sargramostim
16
humanized 3F8 anti-GD2 monoclonal antibody
16
dinutuximab
16
Granulocyte-Macrophage Colony-Stimulating Factor
16
fludarabine
15
Vincristine
15
Doxorubicin
15
Cisplatin
15
Peripheral Blood Stem Cell Transplantation
14
Interleukin-2
14
Busulfan
13
naxitamab
12
Thiotepa
12
Radiotherapy
12
aldesleukin
11
fludarabine phosphate
10
etoposide phosphate
8
Mesna
8
Ifosfamide
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neuroblastoma
×
Etanercept
×
Clear all
NCT03294954
2025-09-19
GINAKIT2
Baylor College of Medicine
Phase 1
Recruiting
70 enrolled